Rentokil Initial (RTO)
(Delayed Data from NYSE)
$32.55 USD
+0.35 (1.09%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $32.54 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum D VGM
Rentokil Initial PLC (RTO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$32.75 | $35.00 | $30.50 | 1.71% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Rentokil Initial PLC comes to $32.75. The forecasts range from a low of $30.50 to a high of $35.00. The average price target represents an increase of 1.71% from the last closing price of $32.20.
Analyst Price Targets (2 )
Broker Rating
Rentokil Initial PLC currently has an average brokerage recommendation (ABR) of 1.92 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.82 a month ago based on 11 recommendations.
Of the 12 recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 50% and 8.33% of all recommendations. A month ago, Strong Buy made up 54.55%, while Buy represented 9.09%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/RTO.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 7 | 6 | 6 | 6 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 5 | 4 | 4 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.92 | 1.75 | 1.82 | 1.56 | 1.56 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/26/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
7/25/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/22/2024 | Not Identified | Not Identified | Not Available | Hold |
7/5/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/1/2024 | UBS | Nicole Manion | Not Available | Hold |
5/16/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
4/8/2024 | Not Identified | Not Identified | Strong Buy | Hold |
3/18/2024 | Exane BNP Paribas | Andrew Grobler | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.92 |
ABR (Last week) | 1.75 |
# of Recs in ABR | 12 |
Average Target Price | $32.75 |
LT Growth Rate | 7.30% |
Industry | Business - Services |
Industry Rank by ABR | 102 of 253 |
Current Quarter EPS Est: | NA |